Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Helitra.com 4 days ago Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha
